All these results suggest that the NLRP3 inflammasome may be an important pathogenic factor for the development of diabetic nephropathy, which is probably a new target for treatment of DN complications in the kidney (Segelmark and Hellmark, 2010). The gene discussed is NLRP3; the disease is diabetic kidney disease.